TechConnect Summit 2011

Cerium oxide nanoparticles for treatment and prevention of Alzheimer’s disease, Parkinson’s disease, and disorders associated with free radical production and/or mitochondrial dysfunction.

Organization:Virginia Coll. of Osteopathic Medicine, VA, US
I.P. Brief:This IP covers the use of cerium oxide nanoparticles in treatment and prevention of neurodegenerative disorders.
Keywords:nanomedicine, nanopharmaceuticals, antioxidants, free radical scavengers, mitochondrial protectants, neurodegeerative disorders, trauma, Parkinson\'s, Alzheimers
Primary Industry:Pharmaceuticals

Full IP Descriptions available on-site.


TechConnect World 2011 Nanotech 2011 Clean Technology 2011 Microtech 2011 BioNanotech 2011 TechConnect Summit 2011
Program | Exhibit/Sponsor | Press | Venue | Register
Short Courses | News | Subscribe | Contact | Site Map
© Copyright 2010 TechConnect World. All Rights Reserved.